These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 24012036

  • 1. Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study).
    Cha KS, Cho KI, Seo JS, Choi JH, Park YH, Yang DH, Hong GR, Kim DS.
    Am J Cardiol; 2013 Dec 01; 112(11):1834-9. PubMed ID: 24012036
    [Abstract] [Full Text] [Related]

  • 2. Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome.
    Chon MK, Cho KI, Cha KS, Seo JS, Kim DS.
    J Cardiol; 2017 May 01; 69(5):741-746. PubMed ID: 27492657
    [Abstract] [Full Text] [Related]

  • 3. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
    Rex S, Schaelte G, Metzelder S, Flier S, de Waal EE, Autschbach R, Rossaint R, Buhre W.
    Acta Anaesthesiol Scand; 2008 Jan 01; 52(1):65-72. PubMed ID: 17976224
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
    Agapito AF, Sousa L, Oliveira JA, Feliciano J, Cacela D, Quininha J.
    Rev Port Cardiol; 2005 Mar 01; 24(3):421-31. PubMed ID: 15929625
    [Abstract] [Full Text] [Related]

  • 6. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B, Richter M, Drömann D, Klose H, Schwaiblmair M, Gruenig E, Ewert R, Kirchner MC, Kleinjung F, Irrgang V, Mueller C.
    J Med Internet Res; 2021 Oct 08; 23(10):e25163. PubMed ID: 34623313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T, Prokakis C, Athanasopoulos G, Thanopoulos A, Rellia P, Zarkalis D, Kogerakis N, Koletsis EN, Bairaktaris A.
    Ann Thorac Surg; 2012 Sep 08; 94(3):792-8. PubMed ID: 22727248
    [Abstract] [Full Text] [Related]

  • 10. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
    Theodoraki K, Rellia P, Thanopoulos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T.
    Can J Anaesth; 2002 Nov 08; 49(9):963-7. PubMed ID: 12419726
    [Abstract] [Full Text] [Related]

  • 11. Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.
    Saggar R, Khanna D, Vaidya A, Derhovanessian A, Maranian P, Duffy E, Belperio JA, Weigt SS, Dua S, Shapiro SS, Goldin JG, Abtin F, Lynch JP, Ross DJ, Forfia PR, Saggar R.
    Thorax; 2014 Feb 08; 69(2):123-9. PubMed ID: 24431095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W, Aerosolized Iloprost Randomized Study Group.
    N Engl J Med; 2002 Aug 01; 347(5):322-9. PubMed ID: 12151469
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D, Hachulla E, Hatron PY, Goullard L, Onimus T, Robin S, Fauchais AL, Queyrel V, Michon-Pasturel U, Hebbar M, Saulnier F, Devulder B.
    J Rheumatol; 2001 Oct 01; 28(10):2252-6. PubMed ID: 11669165
    [Abstract] [Full Text] [Related]

  • 16. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.
    Int J Cardiol; 2012 Mar 22; 155(3):378-82. PubMed ID: 21081251
    [Abstract] [Full Text] [Related]

  • 17. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ.
    Respiration; 2008 Mar 22; 76(2):154-9. PubMed ID: 17804899
    [Abstract] [Full Text] [Related]

  • 18. Long-term inhaled iloprost use in children with pulmonary arterial hypertension.
    Alehan D, Yıldırım I, Sahin M, Ozkutlu S, Ozer S, Karagöz T.
    Cardiol Young; 2012 Aug 22; 22(4):396-403. PubMed ID: 22067137
    [Abstract] [Full Text] [Related]

  • 19. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L, Yang YH, Cui N, Xie WM, Zhai ZG, Ma ZH, Wang C.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2103-5. PubMed ID: 20058612
    [Abstract] [Full Text] [Related]

  • 20. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar 11; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.